US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 5.010
  • -0.270-5.11%
Trading Nov 29 12:07 ET
96.80MMarket Cap-4318P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-4.34%19.13M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
248.19%19.99M
-Cash and cash equivalents
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-4.34%19.13M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
248.19%19.99M
Other current assets
-32.02%138K
-46.63%182K
-66.22%250K
-85.68%59K
-85.68%59K
-83.44%203K
-48.80%341K
-20.00%740K
352.75%412K
352.75%412K
Total current assets
-22.26%17.31M
-26.63%18.3M
21.63%19.71M
-5.98%19.19M
-5.98%19.19M
-10.47%22.26M
75.17%24.94M
-8.00%16.21M
249.82%20.41M
249.82%20.41M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-22.26%17.31M
-26.63%18.3M
21.63%19.71M
-5.98%19.19M
-5.98%19.19M
-10.47%22.26M
75.17%24.94M
-8.00%16.21M
206.52%20.41M
206.52%20.41M
Liabilities
Current liabilities
Payables
-35.25%2.26M
-16.17%1.85M
-16.08%1.76M
-17.53%2.77M
-17.53%2.77M
20.79%3.49M
24.06%2.2M
-7.67%2.1M
78.53%3.36M
78.53%3.36M
-accounts payable
-35.25%2.26M
2.38%1.85M
-16.08%1.76M
-4.78%2.77M
-4.78%2.77M
55.13%3.49M
25.73%1.8M
55.37%2.1M
175.05%2.91M
175.05%2.91M
-Other payable
----
----
----
----
----
----
17.01%399K
----
-45.39%450K
-45.39%450K
Current accrued expenses
78.48%282K
-45.71%310K
211.54%486K
-6.74%415K
-6.74%415K
-78.59%158K
-27.72%571K
-77.62%156K
12.66%445K
12.66%445K
Current liabilities
13.27%6.32M
25.19%5.77M
44.69%5.69M
12.90%6.98M
12.90%6.98M
24.13%5.58M
68.33%4.61M
28.60%3.93M
155.73%6.19M
155.73%6.19M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
13.27%6.32M
25.19%5.77M
44.69%5.69M
12.90%6.98M
12.90%6.98M
24.13%5.58M
68.33%4.61M
28.60%3.93M
-64.98%6.19M
-64.98%6.19M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-40.68%-67M
-50.55%-62.84M
-62.11%-58.42M
-69.60%-54.25M
-69.60%-54.25M
-88.32%-47.62M
-115.03%-41.74M
-127.44%-36.03M
-147.95%-31.99M
-147.95%-31.99M
Paid-in capital
21.27%77.99M
21.42%75.37M
49.95%72.44M
43.81%66.45M
43.81%66.45M
40.83%64.31M
100.81%62.07M
58.90%48.31M
2,342.07%46.2M
2,342.07%46.2M
Total stockholders'equity
-34.13%10.99M
-38.38%12.53M
14.24%14.02M
-14.19%12.2M
-14.19%12.2M
-18.10%16.69M
76.80%20.33M
-15.69%12.27M
229.17%14.22M
229.17%14.22M
Total equity
-34.13%10.99M
-38.38%12.53M
14.24%14.02M
-14.19%12.2M
-14.19%12.2M
-18.10%16.69M
76.80%20.33M
-15.69%12.27M
229.17%14.22M
229.17%14.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -22.17%17.17M-26.36%18.12M25.83%19.46M-4.34%19.13M-4.34%19.13M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M248.19%19.99M
-Cash and cash equivalents -22.17%17.17M-26.36%18.12M25.83%19.46M-4.34%19.13M-4.34%19.13M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M248.19%19.99M
Other current assets -32.02%138K-46.63%182K-66.22%250K-85.68%59K-85.68%59K-83.44%203K-48.80%341K-20.00%740K352.75%412K352.75%412K
Total current assets -22.26%17.31M-26.63%18.3M21.63%19.71M-5.98%19.19M-5.98%19.19M-10.47%22.26M75.17%24.94M-8.00%16.21M249.82%20.41M249.82%20.41M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -22.26%17.31M-26.63%18.3M21.63%19.71M-5.98%19.19M-5.98%19.19M-10.47%22.26M75.17%24.94M-8.00%16.21M206.52%20.41M206.52%20.41M
Liabilities
Current liabilities
Payables -35.25%2.26M-16.17%1.85M-16.08%1.76M-17.53%2.77M-17.53%2.77M20.79%3.49M24.06%2.2M-7.67%2.1M78.53%3.36M78.53%3.36M
-accounts payable -35.25%2.26M2.38%1.85M-16.08%1.76M-4.78%2.77M-4.78%2.77M55.13%3.49M25.73%1.8M55.37%2.1M175.05%2.91M175.05%2.91M
-Other payable ------------------------17.01%399K-----45.39%450K-45.39%450K
Current accrued expenses 78.48%282K-45.71%310K211.54%486K-6.74%415K-6.74%415K-78.59%158K-27.72%571K-77.62%156K12.66%445K12.66%445K
Current liabilities 13.27%6.32M25.19%5.77M44.69%5.69M12.90%6.98M12.90%6.98M24.13%5.58M68.33%4.61M28.60%3.93M155.73%6.19M155.73%6.19M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 13.27%6.32M25.19%5.77M44.69%5.69M12.90%6.98M12.90%6.98M24.13%5.58M68.33%4.61M28.60%3.93M-64.98%6.19M-64.98%6.19M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -40.68%-67M-50.55%-62.84M-62.11%-58.42M-69.60%-54.25M-69.60%-54.25M-88.32%-47.62M-115.03%-41.74M-127.44%-36.03M-147.95%-31.99M-147.95%-31.99M
Paid-in capital 21.27%77.99M21.42%75.37M49.95%72.44M43.81%66.45M43.81%66.45M40.83%64.31M100.81%62.07M58.90%48.31M2,342.07%46.2M2,342.07%46.2M
Total stockholders'equity -34.13%10.99M-38.38%12.53M14.24%14.02M-14.19%12.2M-14.19%12.2M-18.10%16.69M76.80%20.33M-15.69%12.27M229.17%14.22M229.17%14.22M
Total equity -34.13%10.99M-38.38%12.53M14.24%14.02M-14.19%12.2M-14.19%12.2M-18.10%16.69M76.80%20.33M-15.69%12.27M229.17%14.22M229.17%14.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data